MetaADEDB 2.0 @ LMMD
Drug-disease interaction
(UMLS:C3805130)
UMLS ID:
C3805130
MeSH ID:
N/A
Synonym(s)
1.
Drug-disease interaction
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1TestosteroneFAERS: 11US FAERS
2BaclofenFAERS: 6US FAERS
3Valproic AcidFAERS: 4US FAERS
4AmoxicillinFAERS: 3US FAERS
5CitalopramFAERS: 3US FAERS
6GabapentinFAERS: 3US FAERS
7AcetaminophenFAERS: 2US FAERS
8AllopurinolFAERS: 2US FAERS
9Breo ElliptaFAERS: 2US FAERS
10ClozapineFAERS: 2US FAERS
11HydrochlorothiazideFAERS: 2US FAERS
12LamotrigineFAERS: 2US FAERS
13PhenytoinFAERS: 2US FAERS
14SulfamethoxazoleFAERS: 2US FAERS
15WarfarinFAERS: 2US FAERS
16AcetazolamideFAERS: 1US FAERS
17CiprofloxacinFAERS: 1US FAERS
18CitalopramFAERS: 1US FAERS
19Clorazepate DipotassiumFAERS: 1US FAERS
20DiphenhydramineFAERS: 1US FAERS
21DroxidopaFAERS: 1US FAERS
22EpinephrineFAERS: 1US FAERS
23FentanylFAERS: 1US FAERS
24FluoxetineFAERS: 1US FAERS
25FluticasoneFAERS: 1US FAERS
26Imatinib MesylateFAERS: 1US FAERS
27Iron citrateFAERS: 1US FAERS
28LevetiracetamFAERS: 1US FAERS
29LiraglutideFAERS: 1US FAERS
30Loratadine and pseudoephedrine sulfateFAERS: 1US FAERS
31MetforminFAERS: 1US FAERS
32MethotrexateFAERS: 1US FAERS
33MetoclopramideFAERS: 1US FAERS
34OctreotideFAERS: 1US FAERS
35OxycodoneFAERS: 1US FAERS
36Pyridostigmine BromideFAERS: 1US FAERS
37RivaroxabanFAERS: 1US FAERS
38SertralineFAERS: 1US FAERS
39SimvastatinFAERS: 1US FAERS
40SulfasalazineFAERS: 1US FAERS
41TiclopidineFAERS: 1US FAERS
42Tin FluoridesFAERS: 1US FAERS
43TopiramateFAERS: 1US FAERS
44Valproic AcidFAERS: 1US FAERS
45apremilastFAERS: 1US FAERS
46bupropion hydrochloride, naltrexone hydrochoride drug combinationFAERS: 1US FAERS
47suvorexantFAERS: 1US FAERS
48tasimelteonFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.